Estrogen-Induced Regulatory B Cells Protect Against EAE & Limit CNS Inflammation

雌激素诱导的调节性 B 细胞可预防 EAE

基本信息

  • 批准号:
    8851694
  • 负责人:
  • 金额:
    $ 33.69万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-06-01 至 2016-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Multiple sclerosis (MS) is a devastating neurodegenerative disease, characterized by chronic inflammation and demyelination. The incidence of MS is 2-3 times higher in women. However, the relapse rate of MS decreases during late pregnancy and also after treatment with pregnancy levels of estriol (a form of estrogen), leading to a decrease in CNS lesions. Estrogen (E2) is a potent regulator of the immune system and may also act directly on cells of the CNS, including microglia, astrocytes, oligodendrocytes and neurons. Our laboratory has convincingly demonstrated that estrogens exert a pronounced protective effect on clinical and histological disease in the animal model of multiple sclerosis (MS), experimental autoimmune encephalomyelitis (EAE). Immunoregulatory properties of estrogen include dampening proinflammatory cells (e.g. dendritic cells, macrophages and encephalitogenic T cells) and activating Breg and Treg cells. Our goal is to determine the immune-mediated mechanisms that lead to protection of CNS cells (e.g. neurons, oligodendrocytes and microglia, MG). Deciphering the neuroprotective and immunoregulatory effects of estrogen is important for its possible clinical application. Our recent findings demonstrate a requirement for B-cells in E2-mediated protection against EAE involving direct E2 effects on Breg cells mediated through ER¿ and the PD-1/PD-L negative co-inhibitory pathway. It is likely that chronically activated microglia cause the neuronal and axonal degeneration that occurs in progressive forms of MS. Since the cause of this chronic microglial activation is uncertain, we propose in this application that MG cells represent one major target for regulatory B-cells and other B-cell subsets, whether by secretion of IL-10 or via direct means (cell-cell PD-1/PD-L signaling). In summary, this proposal will contribute new information regarding the potential role of E2 on B-cell subsets in regulating MG activation and protection against EAE.
描述(由申请人提供):多发性硬化症(MS)是一种破坏性神经退行性疾病,其特征在于慢性炎症和脱髓鞘。MS的发病率在女性中高出2-3倍。然而,MS的复发率在妊娠晚期以及用妊娠水平的雌三醇(一种雌激素)治疗后降低,导致CNS病变减少。雌激素(E2)是免疫系统的有效调节剂,并且还可以直接作用于CNS的细胞,包括小胶质细胞、星形胶质细胞、少突胶质细胞和神经元。我们的实验室已经令人信服地证明,雌激素在多发性硬化症(MS),实验性自身免疫性脑脊髓炎(EAE)的动物模型的临床和组织学疾病发挥显着的保护作用。雌激素的免疫调节特性包括抑制促炎细胞(例如树突细胞、巨噬细胞和致脑炎性T细胞)和激活布雷格和Treg细胞。我们的目标是确定免疫介导的机制,导致保护中枢神经系统细胞(如神经元,少突胶质细胞和小胶质细胞,MG)。解读雌激素的神经保护和免疫调节作用对其可能的临床应用具有重要意义。我们最近的研究结果表明,在E2介导的EAE保护中需要B细胞,E2通过ER和PD-1/PD-L阴性共抑制途径介导对布雷格细胞的直接作用。可能的是,慢性活化的小胶质细胞引起在MS的进行性形式中发生的神经元和轴突变性。由于这种慢性小胶质细胞活化的原因是不确定的,我们在本申请中提出MG细胞代表调节性B细胞和其他B细胞亚群的一个主要靶标,无论是通过分泌IL-10还是通过直接手段(细胞-细胞PD-1/PD-L信号传导)。总之,这项建议将有助于新的信息E2对B细胞亚群的潜在作用,在调节MG激活和保护EAE。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Halina Offner其他文献

Halina Offner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Halina Offner', 18)}}的其他基金

Compensatory mechanisms of estrogen mediated protection from EAE in IL-10 KO mice
IL-10 KO 小鼠雌激素介导的 EAE 保护的补偿机制
  • 批准号:
    10263144
  • 财政年份:
    2020
  • 资助金额:
    $ 33.69万
  • 项目类别:
Estrogen-Induced Regulatory B Cells Protect Against EAE & Limit CNS Inflammation
雌激素诱导的调节性 B 细胞可预防 EAE
  • 批准号:
    8660356
  • 财政年份:
    2013
  • 资助金额:
    $ 33.69万
  • 项目类别:
Estrogen-Induced Regulatory B Cells Protect Against EAE & Limit CNS Inflammation
雌激素诱导的调节性 B 细胞可预防 EAE
  • 批准号:
    9293408
  • 财政年份:
    2013
  • 资助金额:
    $ 33.69万
  • 项目类别:
Estrogen-Induced Regulatory B Cells Protect Against EAE & Limit CNS Inflammation
雌激素诱导的调节性 B 细胞可预防 EAE
  • 批准号:
    8558759
  • 财政年份:
    2013
  • 资助金额:
    $ 33.69万
  • 项目类别:
Estrogen-Induced Regulatory B Cells Protect Against EAE & Limit CNS Inflammation
雌激素诱导的调节性 B 细胞可预防 EAE
  • 批准号:
    9068255
  • 财政年份:
    2013
  • 资助金额:
    $ 33.69万
  • 项目类别:
Sex differences in brain inflammation in experimental stroke
实验性脑卒中脑部炎症的性别差异
  • 批准号:
    8629805
  • 财政年份:
    2012
  • 资助金额:
    $ 33.69万
  • 项目类别:
Regulatory B-cells Limit CNS Inflammation and Infarct in Experimental Stroke
调节性 B 细胞限制实验性中风中的中枢神经系统炎症和梗死
  • 批准号:
    8186316
  • 财政年份:
    2011
  • 资助金额:
    $ 33.69万
  • 项目类别:
Regulatory B-cells Limit CNS Inflammation and Infarct in Experimental Stroke
调节性 B 细胞限制实验性中风中的中枢神经系统炎症和梗塞
  • 批准号:
    8690181
  • 财政年份:
    2011
  • 资助金额:
    $ 33.69万
  • 项目类别:
Regulatory B-cells Limit CNS Inflammation and Infarct in Experimental Stroke
调节性 B 细胞限制实验性中风中的中枢神经系统炎症和梗塞
  • 批准号:
    8509042
  • 财政年份:
    2011
  • 资助金额:
    $ 33.69万
  • 项目类别:
Regulatory B-cells Limit CNS Inflammation and Infarct in Experimental Stroke
调节性 B 细胞限制实验性中风中的中枢神经系统炎症和梗死
  • 批准号:
    8320086
  • 财政年份:
    2011
  • 资助金额:
    $ 33.69万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 33.69万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 33.69万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 33.69万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 33.69万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 33.69万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 33.69万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 33.69万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 33.69万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 33.69万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 33.69万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了